India plans central licensing for all sterile drug products
India plans to bring all sterile drug products under a central licensing system, tightening oversight of injectables and other sterile medicines. The plan follows about 240 injection samples found not to be of standard quality in fiscal 2026, according to two officials.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.